Important Announcement

Based on recommendations from the U.S. Centers for Disease Control (CDC) and the Food and Drug Administration (FDA), the New York State Department of Health (DOH) has paused the use of the Janssen/Johnson & Johnson COVID-19 vaccine while federal officials evaluate reports of serious adverse health effects experienced by a small number of people who received the J&J vaccine.

The Resource Center administered the J&J vaccine to some people at vaccination clinics April 8 and 9, so we want those people to be aware of the potential for a serious type of blood clot to develop. The CDC, FDA and DOH recommend that people who received the J&J vaccine monitor their health for three weeks after receiving the vaccine. Anyone who experiences severe headache, abdominal pain, leg pain, or shortness of breath during that time should immediately contact their health care provider, or a hospital in the event of an emergency. People who don’t have a medical provider may contact TRC Community Health Center.

The CDC and FDA say that reports of people developing the serious blood clot are rare (six reported cases out of more than 6.8 million people who received the J&J vaccine). The Resource Center urges everyone who has received the J&J vaccine to watch for updates from the CDC (www.cdc.gov) and the DOH (www.coronavirus.health.ny.gov/latest-news).